DP

Diadema Partners Portfolio holdings

AUM $168M
1-Year Est. Return 163.97%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+163.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$168M
AUM Growth
+$24.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
152
New
Increased
Reduced
Closed

Top Buys

1 +$13.1M
2 +$7.65M
3 +$5.07M
4
UTHR icon
United Therapeutics
UTHR
+$4.66M
5
BBIO icon
BridgeBio Pharma
BBIO
+$4.59M

Top Sells

1 +$13.5M
2 +$8.74M
3 +$8.25M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$7.23M
5
BMY icon
Bristol-Myers Squibb
BMY
+$5.86M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWTX icon
51
Edgewise Therapeutics
EWTX
$3.05B
$744K 0.44%
+30,000
VRDN icon
52
Viridian Therapeutics
VRDN
$2.8B
$657K 0.39%
+21,114
INDV icon
53
Indivior Pharmaceuticals
INDV
$3.86B
$621K 0.37%
17,320
-236,932
VIR icon
54
Vir Biotechnology
VIR
$1.24B
$603K 0.36%
+100,000
LGND icon
55
Ligand Pharmaceuticals
LGND
$4.02B
$565K 0.34%
+2,987
UPB
56
Upstream Bio Inc
UPB
$398M
$557K 0.33%
+20,500
STOK icon
57
Stoke Therapeutics
STOK
$1.93B
$545K 0.32%
+17,181
EQ icon
58
Equillium
EQ
$108M
$538K 0.32%
347,393
+47,393
URGN icon
59
UroGen Pharma
URGN
$881M
$511K 0.3%
21,810
-68,190
IMNM icon
60
Immunome
IMNM
$2.38B
$483K 0.29%
+22,500
PALI icon
61
Palisade Bio
PALI
$252M
$390K 0.23%
+166,049
PRQR icon
62
ProQR Therapeutics
PRQR
$158M
$338K 0.2%
167,532
+9,838
HRMY icon
63
Harmony Biosciences
HRMY
$1.63B
$281K 0.17%
7,500
-42,500
AARD
64
Aardvark Therapeutics
AARD
$107M
$208K 0.12%
+15,882
NEUP
65
Neuphoria Therapeutics
NEUP
$23.4M
$194K 0.12%
50,000
+28,548
PLRX icon
66
Pliant Therapeutics
PLRX
$76.8M
$177K 0.11%
+144,914
ONC
67
BeOne Medicines Ltd
ONC
$32.9B
$173K 0.1%
+7,500
FHTX icon
68
Foghorn Therapeutics
FHTX
$323M
$165K 0.1%
30,630
-19,370
TLPH icon
69
Talphera
TLPH
$41.7M
$156K 0.09%
+136,923
PRTC
70
PureTech Health
PRTC
$417M
$124K 0.07%
7,442
+118
INBX icon
71
Inhibrx
INBX
$1.08B
$103K 0.06%
+1,299
EDSA icon
72
Edesa Biotech
EDSA
$36.3M
$76.7K 0.05%
+54,025
VTGN icon
73
VistaGen Therapeutics
VTGN
$24.2M
$66.2K 0.04%
100,000
-249,789
TVRD
74
Tvardi Therapeutics
TVRD
$37M
-2,185
ABUS icon
75
Arbutus Biopharma
ABUS
$902M
0